254 related articles for article (PubMed ID: 12087251)
1. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
Moyer KE; Banducci DR; Graham WP; Ehrlich HP
Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
[TBL] [Abstract][Full Text] [Related]
2. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO
Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
[TBL] [Abstract][Full Text] [Related]
6. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
[TBL] [Abstract][Full Text] [Related]
7. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture.
Seyhan H; Kopp J; Schultze-Mosgau S; Horch RE
Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795
[TBL] [Abstract][Full Text] [Related]
8. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
9. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
10. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
12. Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.
Verjee LS; Midwood K; Davidson D; Essex D; Sandison A; Nanchahal J
J Hand Surg Am; 2009 Dec; 34(10):1785-94. PubMed ID: 19910144
[TBL] [Abstract][Full Text] [Related]
13. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
[TBL] [Abstract][Full Text] [Related]
14. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
15. Contraction of collagen lattices by cells from Dupuytren's nodules.
Tarpila E; Ghassemifar MR; Wingren S; Agren M; Franzén L
J Hand Surg Br; 1996 Dec; 21(6):801-5. PubMed ID: 8982933
[TBL] [Abstract][Full Text] [Related]
16. The collagen changes of Dupuytren's contracture.
Murrell GA; Francis MJ; Bromley L
J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
[TBL] [Abstract][Full Text] [Related]
17. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
18. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
Bisson MA; McGrouther DA; Mudera V; Grobbelaar AO
J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
[TBL] [Abstract][Full Text] [Related]
19. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
[TBL] [Abstract][Full Text] [Related]
20. The role of the fibroblast in Dupuytren's contracture.
Murrell GA
Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
